Yahoo Search Búsqueda en la Web

Resultado de búsqueda

  1. 19 de jun. de 2024 · This study aims to conduct an in-depth genomic analysis of a carbapenem-resistant Proteus mirabilis strain to uncover the distribution and mechanisms of its resistance genes. The research primarily utilized whole-genome sequencing to analyze the genome of the Proteus mirabilis strain.

  2. Hace 2 días · Producción bacteriana de enzimas que inactivan al aminoglucósido. 3.- ... Klebsiella pneumoniae, Serratia marcescens, proteus mirabilis, proteus vulgaris y los generos salmonella y shigella. La estreptomicina es activa contra Mycobacterium tuberculosis, Francisella tularensis, yersinia pestis y Brucella sp.

  3. 28 de jun. de 2024 · Proteus mirabilis is a leading cause of urinary tract infections and a common commensal of the gastrointestinal tract. Our recent study (JB) showed that P. mirabilis strain BL95 employs a novel contact-dependent killing system against enteric bacteria in the mouse gut and in vitro.

  4. 23 de jun. de 2024 · P. mirabilis in terms of the molecular and phenotypic, isolation and identification of P. mirabilis by biochemical tests. Detection of some virulence factors genes and detection of adhesive factors genes using genetic markers. Sample collection possible contamination (Collee et al. 1996). Urine samples

  5. 28 de jun. de 2024 · Pangenome Analysis Reveals Novel Contact-Dependent Growth Inhibition System and Phenazine Biosynthesis Operons in Proteus mirabilis BL95 That Are Located in an Integrative and Conjugative Element. Andrey Tatarenkov 1, Iván Muñoz-Gutiérrez 1, Isabel Vargas 1, Judith Behnsen 2 and Luis Mota-Bravo 1,*. Citation: Tatarenkov, A.; Muñoz-.

  6. 11 de jun. de 2024 · Proteus podría contribuir a su capacidad para invadir el aparato urinario. La producción de la enzima ureasa hidroliza la urea de la orina para formar amoníaco, que aumenta el pH y ayuda a la formación de cálculos.

  7. P. mirabilis is considered to be an ingenious organism capable of initiating crystalline biofilms in a variety of ways. The first stage in the development of biofilms on implanted prosthetic devices usually involves the rapid coating of the device by a conditioning film of host proteins from the surrounding body fluids.